Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 10, Issue 6, pp. 872-887
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 30, 2019
- Revision received February 7, 2020
- Accepted March 18, 2020
- Published first March 21, 2020.
Article Versions
- Previous version (March 21, 2020 - 06:38).
- Previous version (May 11, 2020 - 05:54).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Nathiya Muthalagu1,
- Tiziana Monteverde2,
- Ximena Raffo-Iraolagoitia1,
- Robert Wiesheu2,
- Declan Whyte2,
- Ann Hedley1,
- Sarah Laing2,
- Björn Kruspig2,
- Rosanna Upstill-Goddard3,
- Robin Shaw1,
- Sarah Neidler2,
- Curtis Rink1,
- Saadia A. Karim1,
- Katarina Gyuraszova2,
- Colin Nixon1,
- William Clark1,
- Andrew V. Biankin3,
- Leo M. Carlin1,2,
- Seth B. Coffelt1,2,
- Owen J. Sansom1,2,
- Jennifer P. Morton1,2,* and
- Daniel J. Murphy1,2,*
- 1CRUK Beatson Institute, Glasgow, Scotland, United Kingdom.
- 2Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
- 3Wolfson Wohl Translational Cancer Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom.
- ↵*Corresponding Authors:
Daniel J. Murphy, University of Glasgow, CRUK Beatson Institute, Switchback Road, Glasgow, Scotland G61 1BD, United Kingdom. Phone: 44-141-330-8710; E-mail: daniel.murphy{at}glasgow.ac.uk; and Jennifer P. Morton, Phone: 44-141-330-2802; E-mail: Jennifer.morton{at}glasgow.ac.uk
June 2020
Volume 10, Issue 6
Volume 10, Issue 6
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
Jump to section
Advertisement